SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-055768
Filing Date
2022-09-14
Accepted
2022-09-13 21:59:15
Documents
21
Period of Report
2022-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea165740-8k_inmedpharma.htm   iXBRL 8-K 43664
2 FORM OF PRE-FUNDED WARRANT ea165740ex4-1_inmedpharma.htm EX-4.1 100068
3 FORM OF PREFERRED INVESTMENT OPTION ea165740ex4-2_inmedpharma.htm EX-4.2 104699
4 FORM OF PLACEMENT AGENT PREFERRED INVESTMENT OPTION ea165740ex4-3_inmedpharma.htm EX-4.3 105078
5 FORM OF SECURITIES PURCHASE AGREEMENT ea165740ex10-1_inmedpharma.htm EX-10.1 226465
6 FORM OF REGISTRATION RIGHTS AGREEMENT ea165740ex10-2_inmedpharma.htm EX-10.2 134613
7 PRESS RELEASE DATED SEPTEMBER 9, 2022 ea165740ex99-1_inmedpharma.htm EX-99.1 12744
8 PRESS RELEASE DATED SEPTEMBER 13, 2022 ea165740ex99-2_inmedpharma.htm EX-99.2 12518
9 GRAPHIC ex99-1_001.jpg GRAPHIC 5094
10 GRAPHIC ex99-2_001.jpg GRAPHIC 5094
  Complete submission text file 0001213900-22-055768.txt   1112524

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE inm-20220909.xsd EX-101.SCH 3230
12 XBRL LABEL FILE inm-20220909_lab.xml EX-101.LAB 34240
13 XBRL PRESENTATION FILE inm-20220909_pre.xml EX-101.PRE 22362
15 EXTRACTED XBRL INSTANCE DOCUMENT ea165740-8k_inmedpharma_htm.xml XML 3627
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 221241989
SIC: 2834 Pharmaceutical Preparations